In cohort 1, 9 (34.6%) patients discontinued treatment due to an AE: 7 (26.9%) due to increased ALT, 1 (3.8%) due to hyperthyroidism, and 1 (3.8%) due to ILD. This evidence concerns the gene GPT and interstitial lung disease.